Steven V. Manoukian, MD, FACC
- 7Articles
- 10.4KReads1
- 2004Active
- 10Collaborators
1 Read counts for articles published before 2020 may include some non-human traffic.
About
Steven V. Manoukian, MD, FACC, has published extensively on the metabolic effects of antipsychotic drugs, including their impact on insulin resistance, hyperglycemia, diabetes mellitus, and weight gain. His work addresses the epidemiology of cardiovascular disease and major metabolic risk factors, monitoring metabolic side effects, and treatment recommendations for psychiatrists managing patients with schizophrenia and related metabolic disorders. Manoukian’s research, published in 2004, contributes to understanding the intersection of psychiatric treatment and metabolic health.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.